Engineering Processing Properties of Acetaminophen by Cosolvent Screening - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Engineering Processing Properties of Acetaminophen by Cosolvent Screening
The authors used common solvents to develop an initial solvent-screening method for laboratory-scale research to determine the solubility, polymorphism, and crystal properties of various active ingredients.


Pharmaceutical Technology
Volume 34, Issue 8, pp. 61-68

Results and discussion


Table II: Theoretical yield, apparent heat of solution, Gibb's free energy of dissolution, aspect ratio, enthalpy of melting, and crystallinity of acetaminophen Form I crystals grown from or dissolved in cosolvent systems.
Out of the 100 cosolvent systems, the authors constructed only 92 solubility curves represented as van't Hoff plots because eight cosolvent systems (i.e., THF and N-butyl alcohol, THF and DMF, methanol and DMSO, methanol and 1,4-dioxane, methanol and ethanol, ethanol and 1,4-dioxane, DMSO and benzyl alcohol, and DMF and benzyl alcohol) had exhibited light pink–orange color, thus indicating the possible formation of two side-products of acetaminophen oxidation (i.e., p-benzoquinonemonoimine and p-benzoquinone) (see Table II) (16).




In general, a cosolvent system was a better solubilizer than a single solvent system (7). The theoretical yield (i.e., the amount of crystalline solids that would result if the saturated solution at 60 °C were cooled to 25 °C) was approximated from each solubility curve using the following equation:


Table II (Continued).
where S h is the solubility (g/mL) at 60 °C, and S L is the solubility (g/mL) at 25 °C. The cosolvent system of benzyl alcohol and acetonitrile and the cosolvent system of ethanol and acetone gave a maximum theoretical yield of 71.73% and a minimum of 17.94%, respectively (see Table II). These results implied that the interactions between protic benzyl alcohol and polar aprotic acetonitrile were relatively weak and more sensitive to temperature change than the relatively strong interactions between hydrogen-bond donating ethanol and hydrogen-bond accepting acetone (7).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here